Pfizer Inc surpassed analysts’ expectations for first-quarter earnings on Tuesday, thanks to robust demand for recently acquired drugs and pneumococcal vaccinations, which helped offset the impact of falling sales of its COVID-19 medications. The pharmaceutical company is under pressure to spend the windfall profits from strong demand for its COVID …
Read More »Nasdaq retreats to worst low since 2008 crisis
US equities and stocks plunged on Friday, with the Nasdaq marking its worst month since October 2008 and the S&P notching its worst month since March 2020 at the onset of the Covid pandemic.The tech-heavy Nasdaq fell 4.2% on Friday, dragged down by Amazon (AMZN), which dropped nearly 15% after …
Read More »Nike, Pfizer, Alibaba Stocks Among North America Session’s Winners
Shares of Nike jumped 2.2% after the company reported a beat on the top and bottom lines in the third quarter. The retailer reported earnings of 87 cents per share on revenues of $10.87 billion, topping estimates of 71 cents per share on revenues of $10.59 billion. Nike delayed giving …
Read More »Pfizer Expects $54 Billion in 2022 Sales on Covid Vaccine
Pfizer Inc. recorded quarterly profits above analysts’ expectations, and its revenues rose, but less than estimates, while it expects to record strong sales of its vaccine and treatment for the Coronavirus. Pfizer’s fourth-quarter revenue more than doubled overall to $23.84 billion year-over-year, driven by $12.5 billion in sales of its …
Read More »US Equities Rebound As investors Digest Earnings, Eye Inflation Data
US data and earnings will be in focus this week after big tech earnings spurred large market swings last week. If US economic data triggers an additional repricing of hawkish Fed bets, that risks further downside, particularly for growth and tech shares.US equity markets were able to erase pre-market losses …
Read More »Pfizer and Biotech launch a trial of a vaccine targeting Omicron
Pfizer and Biotech said Tuesday they have started a clinical trial to test a new version of their vaccine specifically designed to target the omicron mutant of COVID-19 that has eluded some of the protection provided by the original two-dose vaccine regimen. The two companies intend to test the immune …
Read More »Could Omicron Worsen Labour Shortage, Slows Economy, Boost Inflation?
The majority of grocery stores have had trouble stocking up during the pandemic due to shortages of supplies and labour. Omicron is adding to the present trouble. Canceled flights, bare shelves at grocery stores, reduced bus schedules and schools closed due to staff shortages are only a few examples.The rapid …
Read More »Market Drivers – US Session – 23-12-2021
For the second day in a row, positive sentiment has dominated financial markets worldwide on the back of some important US economic data and positive news about Covid-19.It is expected that the volume of transactions in the financial markets will witness a noticeable decline in liquidity rates, starting from Friday, …
Read More »US Dollar Index Slides For The Fourth Consecutive Day
The dollar Index (DXY) slides by 0.07% but manages to remain above the 96.02 figure as the New York session winds down. Omicron-related positive news improved market mood.So, improvement in the market sentiment increased the appetite for riskier assets and consequently weakened the dollar’s safe-haven status despite upward bias, though …
Read More »White House Warns Pfizer Pill Won’t Be Widely Available
The White House has dimmed optimism over the Omicron batter after the US Food and Drug Administration approved a pair of pills from Pfizer and Merck to treat Covid-19.The White House has warned it will take more than six months to fulfil its initial order for Pfizer’s antiviral Covid-19 pill, …
Read More »